Catherine Coste

Catherine Coste

Director/Board Member at RENALYTIX PLC

Net worth: 393 453 $ as of 2026-05-30

60 year
Health Technology
Commercial Services
Consumer Services

Profile

Catherine Havlik Coste is currently an Independent Non-Executive Director at Renalytix Plc since 2023 and an Independent Director at BioLife Solutions, Inc. starting in 2025.
Formerly, Ms. Coste was an Independent Director at Biomerica, Inc. from 2020 to 2025, an Independent Director at Minerva Surgical, Inc. from 2021 to 2025, and a Senior Partner at Deloitte & Touche LLP from 1988 to 2020.
Education includes undergraduate studies at California State University-East Bay.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-02-23 13,871 ( 0.03% ) 345 665 $ 2026-05-30
2024-12-12 16,099 ( 0.52% ) 38 444 $ 2026-05-30
2025-09-21 385,129 ( 0.09% ) 9 343 $ 2026-05-30

Catherine Coste active positions

CompaniesPositionStart
RENALYTIX PLC Director/Board Member 2023-06-29
BIOLIFE SOLUTIONS, INC. Director/Board Member 2025-03-17

Former positions of Catherine Coste

CompaniesPositionEnd
BIOMERICA, INC. Director/Board Member 2025-06-03
MINERVA SURGICAL, INC. Director/Board Member 2025-04-30
Corporate Officer/Principal 2020-08-31
See the detail of Catherine Coste's experience

Training of Catherine Coste

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

97

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Technology Services

  1. Stock Market
  2. Insiders
  3. Catherine Coste
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!